Drugs News and Research

RSS

New approach to identify pathogenic genes in virus strains at a glance

When new viruses or bacteria spread to humans, it is essential to clarify their special characteristics as quickly as possible.

27 Feb 2020

Eating less prolongs life

A new study published in the journal Cell in February 2020 reports that eating less is associated with better immunity, reduce inflammation all over the body, and reduced odds of diseases related to old age, as well as increasing the odds of living longer.

27 Feb 2020

Chest CT scan best for coronavirus diagnosis

A new study published in the journal Radiology in February 2020 reports that performing a CT (computed tomography) scan of the chest increases the diagnostic rate and outperforms the reverse-transcription polymerase chain reaction (RT-PCR) tests currently utilized. The researchers recommend using chest CT to screen symptomatic patients for COVID-19 infections rather than the less sensitive RT-PCR.

27 Feb 2020

Boosting immune cells to treat eczema

A new drug regimen is reported to have marked benefits in treating the troublesome and distressing skin condition called eczema. The study, published in February 2020 in the journal Science Translational Medicine, shows that boosting the levels of a type of immune cell called natural killer cells can be a more effective way to treat eczema in a mouse study.

27 Feb 2020

$Implementation of fracture liaison services reduces recurrent fracture risk$

Implementation of fracture liaison services reduces recurrent fracture risk

Older people's risk of recurrent fractures decreases by 18 percent if the care they receive is more structured and preventive, through fracture liaison services. This is shown by a study from the University of Gothenburg, Sweden.

27 Feb 2020

New clinical trial uses universal natural killer cell approach to treat acute myeloid leukemia

A new, phase I clinical trial offered The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute will treat patients with relapsed or refractory acute myeloid leukemia using a novel universal natural killer cell approach.

27 Feb 2020

Pre-operative immunotherapy can elicit an immune response that shrinks oral cancers

A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.

27 Feb 2020

NTHU research team develops new treatment for cancer

A research team led by Dr. Yunching Chen and Tsai-Te Lu of National Tsing Hua University have recently developed a new treatment for cancer, in which blood vessels within malignant tumors are normalized by injecting a specially developed nanodelivery system for nitric oxide (NanoNO), which also facilitates the delivery of cancer drugs and immunocytes into the tumor.

27 Feb 2020

New European collaboration to accelerate lifesaving cancer research

Cancer Research UK and its European partners, Fondazione AIRC and Asociación Española Contra el Cáncer (AECC), will invest £27.4 million into seven new international projects to accelerate lifesaving cancer research, announced today (Friday).

27 Feb 2020

Cases of poisoning attributed to manipulated cannabidiol liquids in e-cigarettes

The health risks of e-cigarettes have come into focus after the deaths of several “vapers” due to lung injury in the USA recently.

27 Feb 2020

They fell in love helping drug users. But fear kept him from helping himself.

She was in medical school. He was just out of prison.

27 Feb 2020

Already approved drugs may hold the key to treating new coronavirus

The number of people infected with the new corona virus continues to skyrocket, with more than 80000 cases worldwide as of the end of February.

27 Feb 2020

New compounds may help stop the spread of the coronavirus

Amid the global health crisis of the coronavirus (COVID-19), scientists from around the world are racing to find a treatment to stop the deadly virus. The sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread across 46 countries, infecting more than 82,000 and killing more than 2,800 people.

26 Feb 2020

Study finds no benefit in using broad-spectrum antibiotics as initial pneumonia treatment

Doctors who use drugs that target antibiotic-resistant bacteria as a first-line defense against pneumonia should probably reconsider this approach, according to a new study of more than 88,000 veterans hospitalized with the disease.

26 Feb 2020

Study reveals the effects of pre-surgical chemotherapy on breast cancer genome

Results from one of the first studies to determine the effects of pre-surgical, or neoadjuvant, chemotherapy on the breast cancer genome offer up two key insights.

26 Feb 2020

New method to deliver an immune system 'uncloaking' device directly to cancer cells

Scientists at Johns Hopkins report they have designed and successfully tested an experimental, super small package able to deliver molecular signals that tag implanted human cancer cells in mice and make them visible for destruction by the animals' immune systems.

26 Feb 2020

Chronic cough could be eased with new drug

A pair of studies have shown that chronic cough and its distressing symptoms could be eased with the help of a new drug. Also, the drug does not have side effects that can restrict its use, explain the researchers. The results of the two studies are published in The Lancet Respiratory Medicine, and the European Respiratory Journal, respectively.

26 Feb 2020

Coronavirus vaccine trials commence

The coronavirus disease (COVID-19) outbreak has swept the world, killing 2,770 people and infecting more than 81,000. Amid the health crisis, scientists from across the globe are racing to develop novel therapies and vaccines in the hope of stemming the spread of the deadly virus.

26 Feb 2020

$Investigational drug reduces heartburn severity in patients with refractory GERD$

Investigational drug reduces heartburn severity in patients with refractory GERD

An investigational drug that binds bile acids in the stomach can reduce the severity of heartburn symptoms in patients with treatment-resistant gastroesophageal reflux disease (GERD) when combined with a proton pump inhibitor (PPI), a new study suggests.

26 Feb 2020

High intake of sugary drinks may influence risk for dyslipidemia

Middle-aged and older adults who drank sugary beverages daily were at greater risk of developing abnormal cholesterol and triglyceride levels compared to those who rarely drank those beverages, according to a new epidemiological study published today in the Journal of the American Heart Association.

26 Feb 2020